Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis

OBJECTIVES: Patients with head and neck squamous cell carcinoma (HNSCC) have poor prognosis and show poor responses to immune checkpoint (IC) inhibitor (ICI) therapy. Competing endogenous RNA (ceRNA) networks, tumor-infiltrating immune cells (TIICs), and ICIs may influence tumor prognosis and respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ya, Pan, Wei Kang, Wang, Zhong Wei, Su, Wang Hui, Xu, Kun, Jia, Hui, Chen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670464/
https://www.ncbi.nlm.nih.gov/pubmed/34917682
http://dx.doi.org/10.1155/2021/4532438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670464/
https://www.ncbi.nlm.nih.gov/pubmed/34917682
http://dx.doi.org/10.1155/2021/4532438

Ejemplares similares